Arkolith/Insider Trading/RLAY/Form 4

Rahmer Peter

See remarksRelay Therapeutics, Inc. (RLAY) · full profile →Form 4 · filed Apr 30, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$37K
Net Open-Market Flow
-$37K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 30, 2025Sell(S)11K$3.00$32K390K
Apr 28, 2025Sell(S)1K$3.17$4K401K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-061367) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML